Elagolix Sodium
Showing 1 - 25 of 3,064
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Elagolix
- +3 more
-
Birmingham, Alabama
- +104 more
Jul 9, 2021
Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)
Active, not recruiting
- Heavy Menstrual Bleeding
- Uterine Fibroids
- Elagolix Placebo
- +3 more
-
Birmingham, Alabama
- +156 more
Jan 20, 2022
Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)
Active, not recruiting
- Endometriosis
- Estradiol/Norethindrone Acetate
- +3 more
-
Birmingham, Alabama
- +196 more
Feb 14, 2022
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Estradiol/Norethindrone Acetate
- Elagolix
-
Birmingham, Alabama
- +123 more
Jul 9, 2021
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix
- +4 more
- (no location specified)
Jul 9, 2021
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Elagolix, Placebo for
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Elagolix
- +3 more
-
Birmingham, Alabama
- +95 more
Jun 9, 2020
Endometriosis Trial in Beijing (Elagolix, Elagolix )
Recruiting
- Endometriosis
- Elagolix
- Elagolix placebo
-
Beijing, Beijing, ChinaPeking University First Hospital
Oct 6, 2023
Oral Elagolix Tablets To Assess Tolerability and Change in
Recruiting
- Endometriosis
-
Ramat Gan, Tel-Aviv, Israel
- +7 more
Jun 8, 2022
Elagolix For the Treatment of Endometriosis in Canada
Completed
- Endometriosis
-
Calgary, Alberta, Canada
- +17 more
Sep 26, 2022
Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets
Recruiting
- Endometriosis
- Uterine Fibrioids
-
Durham, North CarolinaIqvia /Id# 240918
Mar 8, 2022
Endometriosis Trial in Beijing (Elagolix, Elagolix )
Recruiting
- Endometriosis
- Elagolix
- Elagolix placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 11, 2022
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix placebo
- +4 more
- (no location specified)
Jul 7, 2020
Polycystic Ovary Syndrome Trial in Puerto Rico, United States (Elagolix, Placebo)
Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)
Recruiting
- Endometriosis
- Unexplained Infertility
- Elagolix
- Oral Contraceptive
-
Winston-Salem, North CarolinaWake Forest Univesity Health Sciences
Dec 1, 2022
Assess Patient-Reported Quality of Life and Effectiveness on
Recruiting
- Heavy Menstrual Bleeding
- Uterine Fibroids
-
Durham, North CarolinaIQVIA RDS, Inc
Nov 2, 2021
Plasma Sodium and Sodium Administration in the ICU
Recruiting
- Hypernatremia
- +2 more
-
Linköping, SwedenUniversity Hospital Linköping
Sep 15, 2023
Acute Ischemic Stroke Trial in Shanghai (Sodium valproate, Normal saline)
Recruiting
- Acute Ischemic Stroke
- Sodium valproate
- Normal saline
-
Shanghai, Shanghai, ChinaRenji Hospital, Shanghai Jiao Tong University School of Medicine
Aug 26, 2023
SODIUM ACCUMULATION STUDY IN HAEMODIALYSIS: BRAIN STUDY
Not yet recruiting
- Dialysis; Complications
-
Derby, United KingdomCentre for Kidney Research and Innovation
Jul 21, 2023
Hyperkalemia Trial in Alexandria (sodium zirconium cyclosilicate (SZC), sodium polystyrene sulfonate)
Not yet recruiting
- Hyperkalemia
- sodium zirconium cyclosilicate (SZC)
- sodium polystyrene sulfonate
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Sep 7, 2023